PADI4 and systemic lupus erythematosus: Furthermore, it was found in animal models that Cl-amidine, a pan-PAD inhibitor, attenuated the severity of several diseases, such as rheumatoid arthritis [61], systemic lupus erythematosus [32], and cancer [62].